Study on the expression level of serum miR-15a in patients with gestational diabetes mellitus and its relationship with adverse maternal and infant outcomes
10.19405/j.cnki.issn1000-1492.2022.04.027
- Author:
Yuzhuo Ma
1
;
Suyu Chen
1
;
Yujie Liu
1
Author Information
1. Dept of Obstetrics and Gynecology，The First Affiliated Hospital of USTC，Hefei 230002
- Publication Type:Journal Article
- Keywords:
gestational diabetes mellitus;
microRNA-15a;
maternal and infant outcomes;
relationship
- From:
Acta Universitatis Medicinalis Anhui
2022;57(4):650-654
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the change of serum microRNA-15 a(miR-15 a) expression level in patients with gestational diabetes mellitus and its relationship with maternal and infant adverse outcomes.
Methods:143 cases of gestational diabetes mellitus patients were selected as the study group, and 124 healthy pregnant women were selected as the control group, and the expression levels of serum miR-15 a of the two groups were detected by real time fluorescent quantitative reverse transcription polymerase chain reaction(qRT-PCR). Follow up to delivery, the adverse maternal and infant outcomes of the two groups were observed, and the relationship between the expression level of serum miR-15 a and the adverse outcomes of maternal and infant in gestational diabetes mellitus was analyzed by multivariate Logistic regression analysis method.
Results:The expression level of serum miR-15 a in the study group was higher than that in the control group, and the difference was statistically significant(P<0.05). The incidence rates of abortion, premature rupture of membranes, polyhydramnios, postpartum hemorrhage, postpartum infection, premature infants, macrosomia, fetal distress, neonatal asphyxia, neonatal respiratory distress syndrome and neonatal hypoglycemia and the total incidence rates of maternal and perinatal adverse outcomes in the study group were higher than those in the control group(P<0.05), but there was no significant difference in the incidence rate of fetal death between the study group and the control group(P>0.05). The proportions of age>35 years old, pre-pregnancy body mass index ≥24.0 kg/m2, history of adverse pregnancy and childbirth and poor blood glucose control and the expression level of serum miR-15 a in poor maternal outcome group and poor perinatal outcome group were higher than those in good maternal outcome group and good perinatal outcome group(P<0.05), and multivariate Logistic regression analysis showed that the above indicators were the risk factors of adverse maternal and infant outcomes in patients with gestational diabetes mellitus(P<0.05).
Conclusion:The expression level of serum miR-15 a in gestational diabetes mellitus patients abnormally increases, and it can increase the risk of adverse maternal and infant outcomes, which is closely related to the occurrence of adverse maternal and infant outcomes. Besides, the age, pre-pregnancy body mass index, adverse pregnancy history, blood glucose control also have a certain impacts on the occurrence of adverse maternal and infant outcomes in patients with gestational diabetes mellitus.
- Full text:2025021816095721595妊娠期糖尿病患者血清miR...平及其与母婴不良结局的关系_马玉着.pdf
